An artificial intelligence model to predict hepatocellular carcinoma risk in Korean and Caucasian patients with chronic hepatitis B
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Kim, Hwi Young | - |
dc.contributor.author | Lampertico, Pietro | - |
dc.contributor.author | Nam, Joon Yeul | - |
dc.contributor.author | Lee, Hyung-Chul | - |
dc.contributor.author | Kim, Seung Up | - |
dc.contributor.author | Sinn, Dong Hyun | - |
dc.contributor.author | Seo, Yeon Seok | - |
dc.contributor.author | Lee, Han Ah | - |
dc.contributor.author | Park, Soo Young | - |
dc.contributor.author | Lim, Young-Suk | - |
dc.contributor.author | Jang, Eun Sun | - |
dc.contributor.author | Yoon, Eileen L. | - |
dc.contributor.author | Kim, Hyoung Su | - |
dc.contributor.author | Kim, Sung Eun | - |
dc.contributor.author | Ahn, Sang Bong | - |
dc.contributor.author | Shim, Jae-Jun | - |
dc.contributor.author | Jeong, Soung Won | - |
dc.contributor.author | Jung, Yong Jin | - |
dc.contributor.author | Sohn, Joo Hyun | - |
dc.contributor.author | Cho, Yong Kyun | - |
dc.contributor.author | Jun, Dae Won | - |
dc.contributor.author | Dalekos, George N. | - |
dc.contributor.author | Idilman, Ramazan | - |
dc.contributor.author | Sypsa, Vana | - |
dc.contributor.author | Berg, Thomas | - |
dc.contributor.author | Buti, Maria | - |
dc.contributor.author | Calleja, Jose Luis | - |
dc.contributor.author | Goulis, John | - |
dc.contributor.author | Manolakopoulos, Spilios | - |
dc.contributor.author | Janssen, Harry L. A. | - |
dc.contributor.author | Jang, Myoung-jin | - |
dc.contributor.author | Lee, Yun Bin | - |
dc.contributor.author | Kim, Yoon Jun | - |
dc.contributor.author | Yoon, Jung-Hwan | - |
dc.contributor.author | Papatheodoridis, George V. | - |
dc.contributor.author | Lee, Jeong-Hoon | - |
dc.date.accessioned | 2022-03-08T00:40:19Z | - |
dc.date.available | 2022-03-08T00:40:19Z | - |
dc.date.issued | 2022-02 | - |
dc.identifier.issn | 0168-8278 | - |
dc.identifier.issn | 1600-0641 | - |
dc.identifier.uri | https://scholarworks.korea.ac.kr/kumedicine/handle/2021.sw.kumedicine/55363 | - |
dc.description.abstract | Background & Aims Several models have recently been developed to predict risk of hepatocellular carcinoma (HCC) in patients with chronic hepatitis B (CHB). Our aims were to develop and validate an artificial intelligence-assisted prediction model of HCC risk. Methods Using a gradient-boosting machine (GBM) algorithm, a model was developed using 6,051 patients with CHB who received entecavir or tenofovir therapy from 4 hospitals in Korea. Two external validation cohorts were independently established: Korean (5,817 patients from 14 Korean centers) and Caucasian (1,640 from 11 Western centers) PAGE-B cohorts. The primary outcome was HCC development. Results In the derivation cohort and the 2 validation cohorts, cirrhosis was present in 26.9%–50.2% of patients at baseline. A model using 10 parameters at baseline was derived and showed good predictive performance (c-index 0.79). This model showed significantly better discrimination than previous models (PAGE-B, modified PAGE-B, REACH-B, and CU-HCC) in both the Korean (c-index 0.79 vs. 0.64–0.74; all p <0.001) and Caucasian validation cohorts (c-index 0.81 vs. 0.57–0.79; all p <0.05 except modified PAGE-B, p = 0.42). A calibration plot showed a satisfactory calibration function. When the patients were grouped into 4 risk groups, the minimal-risk group (11.2% of the Korean cohort and 8.8% of the Caucasian cohort) had a less than 0.5% risk of HCC during 8 years of follow-up. Conclusions This GBM-based model provides the best predictive power for HCC risk in Korean and Caucasian patients with CHB treated with entecavir or tenofovir. Lay summary Risk scores have been developed to predict the risk of hepatocellular carcinoma (HCC) in patients with chronic hepatitis B. We developed and validated a new risk prediction model using machine learning algorithms in 13,508 antiviral-treated patients with chronic hepatitis B. Our new model, based on 10 common baseline characteristics, demonstrated superior performance in risk stratification compared with previous risk scores. This model also identified a group of patients at minimal risk of developing HCC, who could be indicated for less intensive HCC surveillance. | - |
dc.format.extent | 8 | - |
dc.language | 영어 | - |
dc.language.iso | ENG | - |
dc.publisher | Elsevier BV | - |
dc.title | An artificial intelligence model to predict hepatocellular carcinoma risk in Korean and Caucasian patients with chronic hepatitis B | - |
dc.type | Article | - |
dc.publisher.location | 네델란드 | - |
dc.identifier.doi | 10.1016/j.jhep.2021.09.025 | - |
dc.identifier.scopusid | 2-s2.0-85120864891 | - |
dc.identifier.wosid | 000752560300009 | - |
dc.identifier.bibliographicCitation | Journal of Hepatology, v.76, no.2, pp 311 - 318 | - |
dc.citation.title | Journal of Hepatology | - |
dc.citation.volume | 76 | - |
dc.citation.number | 2 | - |
dc.citation.startPage | 311 | - |
dc.citation.endPage | 318 | - |
dc.type.docType | Article | - |
dc.description.isOpenAccess | N | - |
dc.description.journalRegisteredClass | scie | - |
dc.description.journalRegisteredClass | scopus | - |
dc.relation.journalResearchArea | Gastroenterology & Hepatology | - |
dc.relation.journalWebOfScienceCategory | Gastroenterology & Hepatology | - |
dc.subject.keywordPlus | ENTECAVIR TREATMENT | - |
dc.subject.keywordPlus | SCORING SYSTEM | - |
dc.subject.keywordPlus | VALIDATION | - |
dc.subject.keywordPlus | LAMIVUDINE | - |
dc.subject.keywordPlus | CIRRHOSIS | - |
dc.subject.keywordPlus | THERAPY | - |
dc.subject.keywordPlus | HISTORY | - |
dc.subject.keywordPlus | SCORES | - |
dc.subject.keywordAuthor | liver cancer | - |
dc.subject.keywordAuthor | deep neural networking | - |
dc.subject.keywordAuthor | antiviral treatment | - |
dc.subject.keywordAuthor | chronic hepatitis B | - |
dc.subject.keywordAuthor | HCC | - |
dc.subject.keywordAuthor | HBV | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
73, Goryeodae-ro, Seongbuk-gu, Seoul, Republic of Korea (02841)82-2-2286-1265
COPYRIGHT 2020 KOREA UNIVERSITY MEDICAL LIBRARY ALL RIGHTS RESERVED.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.